Paul Chaplin
Executive Vice President, Research and Development &
CSO
Dr. Chaplin is Managing Director of Bavarian Nordic GmbH and
serves as a member of the Board of Directors of Bavarian Nordic
Inc. and BN ImmunoTherapeutics Inc.
Before joining Bavarian Nordic A/S in 1999, Dr. Chaplin worked for
several years at the Institute for Animal Health in the UK in the
areas of cytokine and dendritic cell biology and in the research
and development of veterinary vaccines at the Cooperative Research
Centre for Vaccine Technology (CSIRO) in Australia.
Dr. Chaplin received his PhD from Bristol University
